Login / Signup

Ligand-Controlled Regiodivergence for Catalytic Stereoselective Semireduction of Allenamides.

Mojtaba Hajiloo ShayeganZhong-Yuan LiXin Cui
Published in: Chemistry (Weinheim an der Bergstrasse, Germany) (2021)
Ligand-controlled regiodivergence has been developed for catalytic semireduction of allenamides with excellent chemo- and stereocontrol. This system also provides an example of catalytic regiodivergent semireduction of allenes for the first time. The divergence of the semireduction is enabled by ligand switch with the same palladium pre-catalyst under operationally simple and mild conditions. Monodentate ligand XPhos exclusively promotes selective 1,2-semireduction to afford allylic amides, while bidentate ligand BINAP completely switched the regioselectivity to 2,3-semireduction, producing (E)-enamide derivatives.
Keyphrases
  • squamous cell carcinoma
  • radiation therapy
  • room temperature
  • drug delivery
  • highly efficient
  • rectal cancer
  • locally advanced